ArticleHealthcare policy = Politiques de sante2009
Media Hyping and the "Herceptin Access Story": An Analysis of Canadian and UK Newspaper Coverage.
Article in Healthcare policy = Politiques de sante, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 47 citations in OpenAlex.
- UK national newspapers' representation of cancer patients and their care during the early part of the COVID-19 pandemic: Invoking and undermining solidarity?Sociology of health & illness · 2024Article
- An empirical ethics study of the coherence of NICE technology appraisal policy and its implications for moral justification.BMC medical ethics · 2024Article
- A systematic review of the print media representation of ketamine treatments for psychiatric disorders.BJPsych open · 2023Review
- News coverage of drug development: implications for the conveyance of health information.BMC public health · 2021Article
- The Law and Ethics of Switching from Biologic to Biosimilar in Canada.Journal of the Canadian Association of Gastroenterology · 2020Article
- Representing a "revolution": how the popular press has portrayed personalized medicine.Genetics in medicine : official journal of the American College of Medical Genetics · 2018Article
- Understanding the reasons for provincial discordance in cancer drug funding-a survey of policymakers.Current oncology (Toronto, Ont.) · 2018Article
- Implicating municipalities in addressing household food insecurity in Canada: A pan-Canadian analysis of news print media coverage.Canadian journal of public health = Revue canadienne de sante publique · 2016Article
- The politicization of oncology drug funding reviews in Canada.Current oncology (Toronto, Ont.) · 2016Article
- Depoliticisation, Resilience and the Herceptin Post-Code Lottery Crisis: Holding Back the Tide.British journal of politics & international relations · 2015Article
- The media and access issues: content analysis of Canadian newspaper coverage of health policy decisions.Orphanet journal of rare diseases · 2015Article
- Pharmacogenetics and the print media: what is the public told?BMC medical genetics · 2015Article
- Health Reporting in Print Media in Lebanon: Evidence, Quality and Role in Informing Policymaking.PloS one · 2015Article
- Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment.Current oncology (Toronto, Ont.) · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In May 2005, preliminary trial results pronouncing the effectiveness of Herceptin (trastuzumab) for treatment of early-stage breast cancer were disseminated at a high-profile scientific meeting. Herceptin was subsequently approved for use in the public healthcare systems of Canada and the United Kingdom, although the differences between the two decision timelines were stark. The authors compared UK and Canadian newspaper coverage of the Herceptin story to assess how it may have been "hyped" in each country. They analyzed a diverse sample of newspapers and coded clippings for reporters' framing of the drug's efficacy, costs and funding approval process. Canadian news coverage preceded formal publication of the trial results, while UK coverage mirrored major national events. Reporters in both countries used predominantly individualistic perspectives and framed Herceptin's efficacy in salutary terms. Framing of costs was more neutral in Canadian than in UK newspapers. Funding approval framing focused on inequitable access in the UK and timeliness in Canada. News coverage of drug access stories varies across jurisdictions in terms of intensity and some aspects of framing. Such variations likely reflect different journalistic practices and dominant political rhetoric. Greater attention should be given to the role that news coverage of drug access plays in shaping public opinion and policy action, especially when this coverage precedes scientific debate.
Identifiers
19377347PMC2653700W2159316293What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.